Portfolio

Omeq Medical

Smart device for epidural injections

Technology Development

Business Development

Revenue

Exited

Founded

2013

CEO
Lior Margalit
UN SDGs
3
Contact Us
email email
Follow Us
linkedin
Investors
The Trendlines Group ; the Israel Innovation Authority, private investors

About

Omeq Medical has developed a single-use, smart epidural needle system for safe, accurate epidural injections.

Attached to a standard epidural needle, a special blunted probe repeatedly monitors the dynamic forces exerted by the surrounding tissues and accurately detects needle penetration into the epidural space. Once successful positioning is confirmed with a visual signal, the device’s safety mechanism protects the patient from inadvertent puncture of the spine.

Omeq Medical received FDA clearance in 2023.

Market Need

Locating the epidural space that surrounds the spinal cord requires extensive physician training and relies heavily on feel. Drugs (“epidurals”) injected into this very narrow space (only 4 millimeters wide) are used for anesthesia and analgesic purposes both during and after surgery.

Inaccurate needle placement occurs in up to 30% of cases, resulting in ineffective drug delivery, multiple insertions, and post-complications such as severe headaches or nerve damage.

Skip to content